RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Surveyor Capital
S

Surveyor Capital portfolio

Surveyor Capital has 2 portfolio companies on record at Recent Funding. Its most recent investment on record is Avalyn Pharma's $100M Series B+ round in September 2023, alongside Wellington Management, Vida Ventures, T. Rowe Price and 6 others. By category, its portfolio leans toward Health and bio (2). It has co-invested with Wellington Management, T. Rowe Price and Rock Springs Capital.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Capital in their rounds: $275M.
Latest deal: Avalyn Pharma · Sep 27, 2023.

What Surveyor Capital invests in

How Surveyor Capital invests

StageDealsCapital in rounds
Series B+ 2 100%$275M

Share is of the 2 rounds on Recent Funding that name Surveyor Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Surveyor Capital portfolio companies

CompanyRound with Surveyor CapitalTotal raisedLatest raise
AAvalyn Pharma
Health and bio
Series B+ · $100M$135.5MSep 27, 2023
Series B+
MMariana Oncology
Health and bio
Series B+ · $175M$175MSep 7, 2023
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Surveyor Capital, which is a subset of its real portfolio. API: /api/v1/investors/surveyor-capital (get a free API key). More: the most active VC firms and new venture capital funds.